FI942499L - Indolijohdannainen, menetelmä sen valmistamiseksi ja sen lääkekäyttö - Google Patents

Indolijohdannainen, menetelmä sen valmistamiseksi ja sen lääkekäyttö Download PDF

Info

Publication number
FI942499L
FI942499L FI942499A FI942499A FI942499L FI 942499 L FI942499 L FI 942499L FI 942499 A FI942499 A FI 942499A FI 942499 A FI942499 A FI 942499A FI 942499 L FI942499 L FI 942499L
Authority
FI
Finland
Prior art keywords
preparation
indole derivative
medicinal use
medicinal
indole
Prior art date
Application number
FI942499A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI942499A7 (fi
FI942499A0 (fi
Inventor
Hiroshi Nagase
Akira Mizusuna
Koji Kawai
Izumi Nakatani
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of FI942499A0 publication Critical patent/FI942499A0/fi
Publication of FI942499A7 publication Critical patent/FI942499A7/fi
Publication of FI942499L publication Critical patent/FI942499L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
FI942499A 1992-09-29 1993-09-29 Indolijohdannainen, menetelmä sen valmistamiseksi ja sen lääkekäyttö FI942499L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25984192 1992-09-29
PCT/JP1993/001388 WO1994007896A1 (fr) 1992-09-29 1993-09-29 Derive indole, procede pour sa fabrication, et son usage medicinal

Publications (3)

Publication Number Publication Date
FI942499A0 FI942499A0 (fi) 1994-05-27
FI942499A7 FI942499A7 (fi) 1994-07-27
FI942499L true FI942499L (fi) 1994-07-27

Family

ID=17339733

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942499A FI942499L (fi) 1992-09-29 1993-09-29 Indolijohdannainen, menetelmä sen valmistamiseksi ja sen lääkekäyttö

Country Status (14)

Country Link
US (2) US6087369A (enExample)
EP (1) EP0614898B1 (enExample)
JP (1) JP3605825B2 (enExample)
KR (1) KR100301093B1 (enExample)
CN (1) CN1043766C (enExample)
AT (1) ATE239732T1 (enExample)
AU (1) AU672033B2 (enExample)
CA (1) CA2124455C (enExample)
DE (1) DE69332945T2 (enExample)
ES (1) ES2199220T3 (enExample)
FI (1) FI942499L (enExample)
NO (1) NO941977L (enExample)
TW (1) TW271440B (enExample)
WO (1) WO1994007896A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2124455C (en) * 1992-09-29 2004-09-14 Hiroshi Nagase Indole derivatives, process for producing the same and medicinal uses of the same
US5464841A (en) * 1993-11-08 1995-11-07 Univ Minnesota Use of delta opioid receptor antagonists to treat immunoregulatory disorders
SE9401727D0 (sv) * 1994-05-18 1994-05-18 Astra Ab New compounds I
SE9401728D0 (sv) * 1994-05-18 1994-05-18 Astra Ab New compounds II
US5578725A (en) * 1995-01-30 1996-11-26 Regents Of The University Of Minnesota Delta opioid receptor antagonists
ES2197953T3 (es) * 1995-09-26 2004-01-16 Toray Industries, Inc. Derivados de indol y aplicaciones medicas de los mismos.
US5994327A (en) * 1995-11-17 1999-11-30 Astra Ab Process for the preparation of morphinans
JP2000503019A (ja) * 1996-01-10 2000-03-14 スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ 複素環縮合モルフィノイド誘導体（ｉｉ）
EP0894799B1 (en) * 1997-01-16 2004-04-07 Toray Industries, Inc. Indolomorphinane derivatives and remedies/preventives for cerebral disorders
DE69839508D1 (de) * 1997-03-31 2008-07-03 Toray Industries Chinolinmorphinan-derivate und ihre medizinische anwendung
US5986141A (en) * 1998-09-29 1999-11-16 Eastman Chemical Company Process for the production of cyclopropanemethylamine
EP1219624B1 (en) * 1999-08-24 2008-07-09 Toray Industries, Inc. Remedies for neuropathic pain and model animals of neuropathic pain
US8205237B2 (en) 2000-09-14 2012-06-19 Cox Ingemar J Identifying works, using a sub-linear time search, such as an approximate nearest neighbor search, for initiating a work-based action, such as an action on the internet
US7232829B2 (en) 2001-04-06 2007-06-19 Regents Of The University Of Minnesota Therapeutic compounds and methods
US6858619B2 (en) 2001-05-04 2005-02-22 Amgen Inc. Fused heterocyclic compounds
US6809104B2 (en) 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
AU2003205332A1 (en) * 2002-01-25 2003-09-02 Philip S. Portoghese Selective analgesic agents
PL376659A1 (pl) 2002-11-06 2006-01-09 Tularik Inc. Skondensowane związki heterocykliczne
EP1595541A1 (en) * 2004-05-12 2005-11-16 Alcasynn Pharmaceuticals Gmbh Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin
EP3077398B1 (en) 2013-12-05 2020-03-11 The University of Bath Novel opioid compounds and their uses

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3631829A1 (de) * 1986-09-19 1988-07-28 Hoechst Ag Klonierung und verwendung des transaminase gens-tyrb
US4816586A (en) * 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
JP2906654B2 (ja) * 1989-11-28 1999-06-21 東レ株式会社 免疫抑制剤及びその製造方法
JPH04342529A (ja) * 1991-05-21 1992-11-30 Toray Ind Inc 抗アレルギー剤
US5225417A (en) * 1992-01-21 1993-07-06 G. D. Searle & Co. Opioid agonist compounds
US5354863A (en) * 1992-01-21 1994-10-11 G. D. Searle & Co. Opioid agonist compounds
US5352680A (en) * 1992-07-15 1994-10-04 Regents Of The University Of Minnesota Delta opioid receptor antagonists to block opioid agonist tolerance and dependence
CA2124455C (en) * 1992-09-29 2004-09-14 Hiroshi Nagase Indole derivatives, process for producing the same and medicinal uses of the same
US5457208A (en) * 1993-06-21 1995-10-10 Regents Of The University Of Minnesota Kappa opioid receptor antagonists
ES2197953T3 (es) * 1995-09-26 2004-01-16 Toray Industries, Inc. Derivados de indol y aplicaciones medicas de los mismos.

Also Published As

Publication number Publication date
FI942499A7 (fi) 1994-07-27
CN1043766C (zh) 1999-06-23
EP0614898B1 (en) 2003-05-07
FI942499A0 (fi) 1994-05-27
EP0614898A1 (en) 1994-09-14
NO941977L (no) 1994-07-29
US6291470B1 (en) 2001-09-18
CN1092425A (zh) 1994-09-21
NO941977D0 (no) 1994-05-27
ATE239732T1 (de) 2003-05-15
ES2199220T3 (es) 2004-02-16
AU672033B2 (en) 1996-09-19
US6087369A (en) 2000-07-11
AU4834193A (en) 1994-04-26
WO1994007896A1 (fr) 1994-04-14
DE69332945D1 (de) 2003-06-12
CA2124455A1 (en) 1994-04-14
DE69332945T2 (de) 2004-05-19
KR100301093B1 (ko) 2001-10-22
CA2124455C (en) 2004-09-14
EP0614898A4 (en) 1994-10-12
TW271440B (enExample) 1996-03-01
JP3605825B2 (ja) 2004-12-22

Similar Documents

Publication Publication Date Title
FI944961L (fi) Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi
FI941137L (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
FI942499A7 (fi) Indolijohdannainen, menetelmä sen valmistamiseksi ja sen lääkekäyttö
FI952230L (fi) Uusi aryylipropaanijohdannainen, menetelmä sen valmistamiseksi ja sen käyttö analgeettisena aineena
FI951468L (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
FI953479A0 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
BG97198A (bg) Диалкокси-пиридинил-бензимидазолови производни, метод за получаването им и тяхното фармацевтично приложение
EE03568B1 (et) Bensimidasooli derivaadid, nende valmistamismeetod ja kasutamine
FI953898A0 (fi) Glysiiniamidijohdannaisia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä lääkeaineita
EE9800302A (et) Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat
FI931336A7 (fi) Polyhydroksimetyleenijohdannaisia sisältäviä lääkkeitä, menetelmä niiden valmistamiseksi ja käyttämiseksi
FI944821L (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
FI935465L (fi) Termoplastinen koostumus, menetelmä sen valmistamiseksi ja sen käyttö
FI944822L (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
FI942932A7 (fi) Farmaseuttinen koostumus ja menetelmä sen valmistamiseksi
FI922875A7 (fi) Reniiniä estävät yhdisteet, menetelmä niiden valmistamiseksi ja niidenkäyttö
EE9900112A (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
FI944823L (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
FI924869A7 (fi) Kinoliinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden terapeuttinen käyttö
FI944713L (fi) 4-difenyylimetyylipiperidiinijohdannaisia ja menetelmä niiden valmistamiseksi
FI921525A7 (fi) Amidinofenyylialaniinijohdannaisia, menetelmä niiden valmistamiseksi, niiden käyttö ja niitä sisältäviä aineita
EE9800145A (et) Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena
FI940775L (fi) alfa-fenyyli-isoseriinijohdannaisten valmistusmentelmä ja niiden käyttö
FI972988A0 (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
FI931346A7 (fi) Butadieenijohdokset ja menetelmä niiden valmistamiseksi